Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway

Xue,Xiaofei; Ling,Xinyu; Xi,Wang; Wang,Pei; Sun,Jianjun; Yang,Qian; Xiao,Jian

doi:10.3892/mmr.2020.11291

Exogenous hydrogen sulfide reduces atrial remodeling and atrial fibrillation induced by diabetes mellitus via activation of the PI3K/Akt/eNOS pathway

Authors:
- Xiaofei Xue
- Xinyu Ling
- Wang Xi
- Pei Wang
- Jianjun Sun
- Qian Yang
- Jian Xiao
View Affiliations

Affiliations: Center for Comprehensive Treatment of Atrial Fibrillation, Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China, Department of Rehabilitation, Elderly Rehabilitation Hospital, Suzhou Red Cross Society, Suzhou, Jiangsu 215009, P.R. China
Published online on: June 30, 2020 https://doi.org/10.3892/mmr.2020.11291
Pages: 1759-1766
Copyright: © Xue et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetes mellitus (DM) facilitates atrial fibrosis and increases the risk of atrial fibrillation (AF). The underlying mechanism of DM in causing AF remains mostly unknown and potential therapeutic targets for DM‑induced AF are rarely reported. Hydrogen sulfide (H2S) has drawn considerable attention in recent years for its potential as a cardiovascular protector. Thus, the aim of the present study was to investigate the effect of H2S on DM‑induced AF and the mechanism of action. Sprague‑Dawley rats were divided into four groups, including the control group, the DM group, the H2S group and the DM+H2S group. The DM group and the DM+H2S group were administered streptozotocin to induce DM, whereas the other two groups were given citrate buffer as a control. The H2S group and the DM+H2S group were administered with an intraperitoneal injection of sodium hydrosulfide (precursor of H2S). AF inducibility, AF duration, atrial fibrosis and vital protein expression of oxidative stress were compared among the four groups. The DM group showed significantly higher AF incidence rates and duration (P<0.05). Histology results demonstrated severe atrial fibrosis in the DM group, and the PI3K/Akt/endothelial nitric oxide synthase (eNOS) pathway was significantly downregulated (P<0.05). However, when H2S was administered, the rats showed lower AF incidence and duration compared with the DM group. Additionally, H2S was able to mitigate the atrial fibrosis induced by DM, as well as the proliferation and migration of cardiac fibroblasts, as demonstrated by an MTT assay and real‑time cell analyzer migration experiment. Western blotting showed that the expression levels of the PI3K/Akt/eNOS pathway in the DM+H2S group were significantly upregulated compared with those of the DM group (P<0.05). In summary, DM status can lead to the structural remodeling of atrial fibrosis, facilitating AF incidence and persistence. Administration of H2S does not affect the glucose level, but can significantly mitigate atrial fibrosis and reduce the incidence of AF induced by DM, probably via activation of the PI3K/Akt/eNOS pathway.

View Figures

View References

1	Lip GY, Tse HF and Lane DA: Atrial fibrillation. Lancet. 379:648–661. 2012. View Article : Google Scholar : PubMed/NCBI
2	Bell DSH and Goncalves E: Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies. Diabetes Obes Metab. 21:210–217. 2019. View Article : Google Scholar : PubMed/NCBI
3	Proietti R, Russo V, Wu MA, Maggioni AP and Marfella R: Diabetes mellitus and atrial fibrillation: Evidence of a pathophysiological, clinical and epidemiological association beyond the thromboembolic risk. G Ital Cardiol (Rome). 18:199–207. 2017.(In Italian). PubMed/NCBI
4	Saito S, Teshima Y, Fukui A, Kondo H, Nishio S, Nakagawa M, Saikawa T and Takahashi N: Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 104:5–14. 2014. View Article : Google Scholar : PubMed/NCBI
5	Hayami N, Sekiguchi A, Iwasaki YK, Murakawa Y and Yamashita T: No additional effect of DPP-4 inhibitor on preventing atrial fibrosis in streptozotocin-induced diabetic rat as compared with sulfonylurea. Int Heart J. 57:336–340. 2016. View Article : Google Scholar : PubMed/NCBI
6	Karam BS, Chavez-Moreno A, Koh W, Akar JG and Akar FG: Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 16:1202017. View Article : Google Scholar : PubMed/NCBI
7	Wu D, Wang J, Li H, Xue M, Ji A and Li Y: Role of hydrogen sulfide in ischemia-reperfusion injury. Oxid Med Cell Longev. 2015:1869082015. View Article : Google Scholar : PubMed/NCBI
8	Citi V, Piragine E, Testai L, Breschi MC, Calderone V and Martelli A: The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury. Curr Med Chem. 25:4380–4401. 2018. View Article : Google Scholar : PubMed/NCBI
9	Zhang FL, Chu SL, Wang WW and Chen LL: Downregulated PI3K-Akt-eNOS expression is related to increased atrial fibrillation inducibility in diabetic rats. Zhonghua Xin Xue Guan Bing Za Zhi. 46:376–381. 2018.(In Chinese). PubMed/NCBI
10	Olas B: Hydrogen sulfide in signaling pathways. Clin Chim Acta. 439:212–218. 2015. View Article : Google Scholar : PubMed/NCBI
11	Toldo S, Das A, Mezzaroma E, Chau VQ, Marchetti C, Durrant D, Samidurai A, Van Tassell BW, Yin C, Ockaili RA, et al: Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice. Circ Cardiovasc Genet. 7:311–320. 2014. View Article : Google Scholar : PubMed/NCBI
12	Sohrabipour S, Sharifi MR, Talebi A, Sharifi M and Soltani N: GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet. Eur J Pharmacol. 826:75–84. 2018. View Article : Google Scholar : PubMed/NCBI
13	Jin X, Jiang Y, Xue G, Yuan Y, Zhu H, Zhan L, Zhuang Y, Huang Q, Shi L, Zhao Y, et al: Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice. Eur J Pharmacol. 857:1724442019. View Article : Google Scholar : PubMed/NCBI
14	Luo T, Chen B and Wang X: 4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress. Chem Biol Interact. 242:99–106. 2015. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Meng T, Cheng G, Wei Y, Ma S, Jiang Y, Wu J, Zhou X and Sun C: Exposure to a chronic high-fat diet promotes atrial structure and gap junction remodeling in rats. Int J Mol Med. 40:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
17	Shen H, Wang J, Min J, Xi W, Gao Y, Yin L, Yu Y, Liu K, Xiao J, Zhang YF and Wang ZN: Activation of TGF-β1/α-SMA/Col I profibrotic pathway in fibroblasts by galectin-3 contributes to atrial fibrosis in experimental models and patients. Cell Physiol Biochem. 47:851–863. 2018. View Article : Google Scholar : PubMed/NCBI
18	Ma J, Ma S, Yin C and Wu H: Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties. J Cardiovasc Electrophysiol. 29:616–627. 2018. View Article : Google Scholar : PubMed/NCBI
19	Al-Awar A, Kupai K, Veszelka M, Szűcs G, Attieh Z, Murlasits Z, Török S, Pósa A and Varga C: Experimental diabetes mellitus in different animal models. J Diabetes Res. 2016:90514262016. View Article : Google Scholar : PubMed/NCBI
20	Goudis CA, Korantzopoulos P, Ntalas IV, Kallergis EM, Liu T and Ketikoglou DG: Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies. Int J Cardiol. 184:617–622. 2015. View Article : Google Scholar : PubMed/NCBI
21	Chang SH, Wu LS, Chiou MJ, Liu JR, Yu KH, Kuo CF, Wen MS, Chen WJ, Yeh YH and See LC: Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: A population-based dynamic cohort and in vitro studies. Cardiovasc Diabetol. 13:1232014. View Article : Google Scholar : PubMed/NCBI
22	Yang Y, Zhao J, Qiu J, Li J, Liang X, Zhang Z, Zhang X, Fu H, Korantzopoulos P, Letsas KP, et al: Xanthine oxidase inhibitor allopurinol prevents oxidative stress-mediated atrial remodeling in alloxan-induced diabetes mellitus rabbits. J Am Heart Assoc. 7:e0088072018. View Article : Google Scholar : PubMed/NCBI
23	Wang R, Peng L, Zhao J, Zhang L, Guo C, Zheng W and Chen H: Gardenamide a protects RGC-5 cells from H(2)O(2)-induced oxidative stress insults by activating PI3K/Akt/eNOS signaling pathway. Int J Mol Sci. 16:22350–22367. 2015. View Article : Google Scholar : PubMed/NCBI
24	Chu P, Han G, Ahsan A, Sun Z, Liu S, Zhang Z, Sun B, Song Y, Lin Y, Peng J and Tang Z: Phosphocreatine protects endothelial cells from Methylglyoxal induced oxidative stress and apoptosis via the regulation of PI3K/Akt/eNOS and NF-κB pathway. Vascul Pharmacol. 91:26–35. 2017. View Article : Google Scholar : PubMed/NCBI
25	Chong E, Chang SL, Hsiao YW, Singhal R, Liu SH, Leha T, Lin WY, Hsu CP, Chen YC, Chen YJ, et al: Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation. Heart Rhythm. 12:1046–1056. 2015. View Article : Google Scholar : PubMed/NCBI
26	Xiao T, Luo J, Wu Z, Li F, Zeng O and Yang J: Effects of hydrogen sulfide on myocardial fibrosis and PI3K/AKT1-regulated autophagy in diabetic rats. Mol Med Rep. 13:1765–1773. 2016. View Article : Google Scholar : PubMed/NCBI
27	Liu M, Li Z, Liang B, Li L, Liu S, Tan W, Long J, Tang F, Chu C and Yang J: Hydrogen sulfide ameliorates rat myocardial fibrosis induced by thyroxine through PI3K/AKT signaling pathway. Endocr J. 65:769–781. 2018. View Article : Google Scholar : PubMed/NCBI